Damora Therapeutics (DMRA) Return on Assets [ROA] (2020 - 2026)
Damora Therapeutics (DMRA) reported Return on Assets [ROA] of -48.72% for Q2 2026, up 65.50 percentage points from -114.22% a year earlier and up 10.35 percentage points from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025, Damora Therapeutics posted Return on Assets [ROA] of -151.15%, down 73.69 percentage points from FY2024.
- Return on Assets [ROA] has declined for five consecutive years, with a five-year change of -121.67 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -77.45% in FY2024 (-8.61 pp), -68.84% in FY2023 (-6.19 pp), -62.65% in FY2022 (-27.10 pp) and -35.55% in FY2021 (-6.07 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q1 2022.
- Year over year, Return on Assets [ROA] gained in three of the last eight quarters, with an average year-over-year change of -5.95 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 65.50 percentage points); the low point was Q4 2025 (a drop of 48.86 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -59.07% (Q1 2026), -154.71% (Q4 2025) and -129.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Damora Therapeutics | 1.27 Bn | -63.83 Mn | - | -48.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.72% |
| Mar 31, 2026 | -59.07% |
| Dec 31, 2025 | -154.71% |
| Sep 30, 2025 | -129.73% |
| Jun 30, 2025 | -114.22% |
| Mar 31, 2025 | -113.83% |
| Dec 31, 2024 | -105.85% |
| Sep 30, 2024 | -83.57% |
| Jun 30, 2024 | -85.07% |
| Mar 31, 2024 | -87.21% |
| Dec 31, 2023 | -88.01% |
| Sep 30, 2023 | -84.33% |
| Jun 30, 2023 | -83.26% |
| Mar 31, 2023 | -83.82% |
| Dec 31, 2022 | -78.87% |
| Sep 30, 2022 | -69.93% |
| Jun 30, 2022 | -59.93% |
| Mar 31, 2022 | -48.12% |
| Dec 31, 2021 | -40.47% |
| Sep 30, 2021 | -35.42% |
API Access
Damora Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();